These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4226518)

  • 21. Staphylococcal clumping with soluble fibrin mmonomer complexes.
    Lipiński B; Hawiger J; Jeljaszewicz J
    J Exp Med; 1967 Nov; 126(5):979-88. PubMed ID: 4228857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinogen-fibrin breakdown products in pathologic synovial fluids. An immunologic study.
    Gormsen J; Andersen RB; Feddersen C
    Arthritis Rheum; 1971; 14(4):503-12. PubMed ID: 4254709
    [No Abstract]   [Full Text] [Related]  

  • 23. Biological effects of fibrinogen-fibrin degradation products.
    Larrieu MJ; Dray L; Ardaillou N
    Thromb Diath Haemorrh; 1975 Dec; 34(3):686-92. PubMed ID: 1108283
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of temperature on formation of fibrin complexes.
    Edgar W; Prentice CR
    Thromb Res; 1980 Jun; 18(6):759-72. PubMed ID: 6158115
    [No Abstract]   [Full Text] [Related]  

  • 25. Formation and properties of fibrin clots resulting from staphylocoagulase (SC) action.
    Kopeć M; Wegrzynowicz Z; Budzyński AZ; Jeljaszewicz J; Latallo ZS; Lipiński B; Kowalski E
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):475-86. PubMed ID: 5590240
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of sodium and calcium on the conversion of fibrinogen to fibrin].
    Marguerie G; Hudry G; Hollard D
    Thromb Diath Haemorrh; 1970 Dec; 24(3):373-84. PubMed ID: 5503938
    [No Abstract]   [Full Text] [Related]  

  • 27. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of epsilon-aminocaproic acid with the thrombin clotting and fibrinolytic systems.
    Maxwell RE; Allen D
    Nature; 1966 Jan; 209(5019):211-3. PubMed ID: 4223693
    [No Abstract]   [Full Text] [Related]  

  • 29. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J; Niewiarowski S; Gurewich V; Thomas DP
    J Lab Clin Med; 1970 Jan; 75(1):93-108. PubMed ID: 4243578
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of cyanate on clottability of fibrinogen.
    Bell WR; Charache S
    J Lab Clin Med; 1974 May; 83(5):790-6. PubMed ID: 4821857
    [No Abstract]   [Full Text] [Related]  

  • 31. [A functional assay of fibrinoformation in the newborn (author's transl)].
    Merino J; García-Conde J; Benet I
    Sangre (Barc); 1977; 22(4):439-52. PubMed ID: 897954
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of calcium ions on fibrin gel formation in normal plasma.
    Regañón E; Vila V; Aznar J
    Thromb Res; 1984 Aug; 35(3):365-9. PubMed ID: 6463965
    [No Abstract]   [Full Text] [Related]  

  • 33. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H; Markwardt F; Perlewitz J
    Thromb Diath Haemorrh; 1969 Dec; 22(3):552-68. PubMed ID: 5382290
    [No Abstract]   [Full Text] [Related]  

  • 34. [Action of proteolytic enzymes on fibrinogen].
    Jamet M; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative proteolysis of the fibrinogen B beta chain by thrombin and plasmin as a determinant of thrombosis.
    Nossel HL
    Nature; 1981 May; 291(5811):165-7. PubMed ID: 6453297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alkaloids of tobacco and blood coagulation: effect of nicotine on thrombin and fibrinogen.
    Singh JM; Singh MD
    Clin Toxicol; 1975; 8(1):43-52. PubMed ID: 1137933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The action of poly-lysine on the conversion of fibrinogen into fibrin by coagulase thrombin.
    BIEZUNSKI N; SHAFRIR E; DE VRIES A; KATCHALSKI E
    Biochem J; 1955 Jan; 59(1):55-8. PubMed ID: 14351141
    [No Abstract]   [Full Text] [Related]  

  • 38. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutual interaction between platelets and fibrinogen and its derivatives.
    Stachurska J; Wegrzynowicz Z; Latallo ZS; Kopec M
    Acta Univ Carol Med Monogr; 1972; 53():17-20. PubMed ID: 4275439
    [No Abstract]   [Full Text] [Related]  

  • 40. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
    Dempfle CE; Keller A; Argirion S; Heene DL
    Thromb Haemost; 1999 Feb; 81(2):264-7. PubMed ID: 10064004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.